| Literature DB >> 31363809 |
Emel Aygören-Pürsün1, Konrad Bork2.
Abstract
Hereditary angioedema (HAE) encompasses a heterogeneous group of diseases with similar phenotypes but different underlying genotypes. Specific clinical signs may point to HAE as opposed to histaminergic angioedema: the typical prolonged development of angioedema over time, positive family history, a lack of response to antihistamines and steroids and response to bradykinin antagonists are typical signs of HAE. The different types of HAE may be associated with a severe clinical course. They are life-long conditions and are still potentially life-threatening. The quality of life of patients with HAE may be considerably impaired. Management plans should be individualized, which is facilitated by the variety of specific medicastions available.Entities:
Keywords: Bradykinin; Complement C1 inhibitor protein; Factor XII; Hereditary angioedema; Prophylaxis, angioedema
Mesh:
Substances:
Year: 2019 PMID: 31363809 DOI: 10.1007/s00108-019-0644-1
Source DB: PubMed Journal: Internist (Berl) ISSN: 0020-9554 Impact factor: 0.743